Evidence map›Paper›PMID 30079405›Full record

ArticleJournal of clinical genomics2018

Emerging techniques in single-cell epigenomics and their applications to cancer research.

Pang-Kuo Lo, Qun Zhou

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Single-cell multi-omics in the study of digestive system cancers.Computational and structural biotechnology journal · 2024
    Review
  5. Article
  6. Applications of single-cell multi-omics in liver cancer.JHEP reports : innovation in hepatology · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. A Comparative Overview of Epigenomic Profiling Methods.Frontiers in cell and developmental biology · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Pang-Kuo LoDepartment of Biochemistry and Molecular Biology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Qun ZhouDepartment of Biochemistry and Molecular Biology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
U-M Rogel Cancer CenterUniversity of Maryland, Baltimore · US

Funding

miR-140 and Breast Cancer PreventionR01CA163820 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ZHOU, QUN · 2012 to 2016
$1.6M
Shikonin and Nrf2 ChemopreventionR01CA157779 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ZHOU, QUN · 2013 to 2017
$1.4M
BLRD VA I01 BX004264NCI NIH HHS R01 CA157779NCI NIH HHS R01 CA163820
6 · The paper itself

Abstract

Epigenomics encompasses studies of the chemical modifications of genomic DNA and associated histones, interactions between genomic DNA sequences and proteins, the dynamics of the chromosomal conformation, the functional relationships between these epigenetic events, and the regulatory impacts of these epigenetic events on gene expression in cells. In comparison to current techniques that are only capable of characterizing average epigenomic features across bulk cell ensembles, single-cell epigenomic methodologies are emerging as powerful new techniques to study cellular plasticity and heterogeneity, as seen in stem cells and cancer. Here we summarize available techniques for studies of single-cell epigenomics, review their current applications to cancer research, and discuss future possibilities. This review also highlights that the full potential of single-cell epigenetic studies will be comprehended through integrating the multi-omics information of genomics, epigenomics and transcriptomics.

Indexed as

Chemotherapeutic treatmentsEpigenomicsGenomic DNAintratumor heterogeneityOncogenesissingle-cell techniques

Identifiers

PMID30079405
PMCPMC6070152
OpenAlexW2795212387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.